Mason Chilmonczyk net worth
Quick answer
Mason Chilmonczyk's estimated net worth is $18.0M (range $12.6M – $27.0M) as of 2026. Mason Chilmonczyk is Founder at Andson Biotech. Andson Biotech valuation.
Mason Chilmonczyk is Founder at Andson Biotech (YC W22). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Education: Bachelor of Science in Bioengineering from University of California, Berkeley
- Region: United States of America
- Industries: Healthcare
- Team size: 4
- Website: http://www.andsonbiotech.com
Who is Mason Chilmonczyk?
Mason Chilmonczyk is a founder at Andson Biotech, which was part of Y Combinator's Winter 2022 cohort.
Highlights:
- University of California, Berkeley
- Y Combinator
- Andson Biotech
About Andson Biotech
Andson Biotech helps pharmaceutical companies measure difficult to detect chemicals that they need to measure while developing and manufacturing drugs like cell-therapies or biologics. Drug companies want to use our technologies to get fast and accurate chemical measurements they do thousands of times per day for drug development and quality control.
FAQ: Mason Chilmonczyk net worth and Andson Biotech valuation
What is Mason Chilmonczyk's net worth?
Mason Chilmonczyk's estimated net worth is $18.0M (range $12.6M – $27.0M) as of 2026. Mason Chilmonczyk is Founder at Andson Biotech. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Andson Biotech valuation?
Andson Biotech's estimated valuation on Entrepreneurial Check is $18.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Mason Chilmonczyk's role?
Mason Chilmonczyk is Founder at Andson Biotech, a Y Combinator-backed startup (batch W22).